Company
Global Blood Therapeutics, Inc. (0001629137)
Standardized SEC financial data for Global Blood Therapeutics, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001629137 · Pharmaceutical Preparations.
Gross margin
98.3%
Operating margin
-147.7%
Net margin
-155.6%
Revenue growth (YoY)
57.3%
Return on equity
-154.3%
Free cash flow
-$260.0M
Debt / equity
1.83×
Current ratio
9.11×
Ratios for fiscal year 2021, standardized from SEC filings.
Income statement
| USD | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | $2.1M | $123.8M | $194.7M |
| Cost of revenue |
Balance sheet
| USD | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $92.2M | $199.4M | $277.8M | $304.6M | $497.2M | $734.8M |
| Accounts receivable |
Cash flow
| USD | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$67.7M | -$93.0M | -$135.4M | -$194.4M | -$211.9M | -$256.8M |
| Capital expenditures |
Get 0001629137 data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/0001629137/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/0001629137/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"